Literature DB >> 33646324

[Paraneoplastic autoimmune dermatoses].

D Didona1, M Hertl2.   

Abstract

Paraneoplastic skin manifestations associated with malignancies are extremely polymorphous. Clinicians should be familiar with paraneoplastic dermatoses to establish an early diagnosis of the underlying neoplasm. Lack of familiarity with cutaneous clues for internal malignancies may delay diagnosis and treatment of cancer. In this review, we describe several paraneoplastic autoimmune dermatoses, including paraneoplastic autoimmune multiorgan syndrome, paraneoplastic bullous pemphigoid, and paraneoplastic dermatomyositis.

Entities:  

Keywords:  Autoantibodies; Neoplasia; Paraneoplastic autoimmune multiorgan syndrome; Paraneoplastic bullous pemphigoid; Rare skin diseases

Mesh:

Substances:

Year:  2021        PMID: 33646324     DOI: 10.1007/s00105-021-04773-w

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  82 in total

1.  Paraneoplastic pemphigus: the role of tumours and drugs.

Authors:  G J Anhalt
Journal:  Br J Dermatol       Date:  2001-06       Impact factor: 9.302

2.  Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.

Authors:  Kohei Azuma; Hidehiro Yamada; Michiko Ohkubo; Yoshioki Yamasaki; Masaomi Yamasaki; Machiko Mizushima; Shoichi Ozaki
Journal:  Mod Rheumatol       Date:  2010-10-05       Impact factor: 3.023

Review 3.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 4.  Bullous pemphigoid.

Authors:  Işın Sinem Bağcı; Orsolya N Horváth; Thomas Ruzicka; Miklós Sárdy
Journal:  Autoimmun Rev       Date:  2017-03-08       Impact factor: 9.754

Review 5.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

6.  Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes.

Authors:  Kyle T Amber
Journal:  Nat Rev Dis Primers       Date:  2018-02-22       Impact factor: 52.329

7.  Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.

Authors:  Samuel J Balin; David A Wetter; Louise K Andersen; Mark D P Davis
Journal:  Arch Dermatol       Date:  2011-12-19

8.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

9.  Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.

Authors:  Csilla András; Andrea Ponyi; Tamás Constantin; Zoltán Csiki; Eva Szekanecz; Peter Szodoray; Katalin Dankó
Journal:  J Rheumatol       Date:  2008-01-15       Impact factor: 4.666

Review 10.  Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus.

Authors:  Kyle T Amber; Manuel Valdebran; Sergei A Grando
Journal:  Autoimmun Rev       Date:  2018-08-11       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.